The investment
A Compass-led consortium acquires Rameda.
Our portfolio
HEALTHCARE / LISTED
Rameda
A healthier business. A broader horizon.
An Egyptian pharmaceutical business transformed through investment in people, products, and production.
INITIAL INVESTMENT2011
SECTORHealthcare
EGYPTIAN EXCHANGERMDA.CA
THE INVESTMENT STORY
Potential.
Partnership.
Progress.
PharmaceuticalsOperational transformationManufacturing capacity
In 2011, a consortium led by Compass acquired Rameda with a plan to unlock the pharmaceutical company’s potential. The investment combined financial backing with an active role in the business’s development.
The transformation focused on strengthening leadership, improving operations, expanding manufacturing capabilities, and broadening the product portfolio. These changes helped establish a stronger platform for growth in the Egyptian pharmaceutical market.
Rameda listed on the Egyptian Exchange in December 2019. The milestone followed a period of operational development and investment in the foundations of the business.
Visit RamedaKEY MILESTONES
A journey
of development.
Building the platform
Investment in people, production, and the product portfolio supports the transformation.
Public market milestone
Rameda lists on the Egyptian Exchange in December.
CONTINUE EXPLORING
More investment stories.
PUBLICLY LISTEDReal estate
Bonyan
From a single retail asset to a commercial real estate platform, Bonyan reflects the value of a long-term perspective.
REALISED INVESTMENTFinancial services
CI Capital
An investment in a diversified financial services platform, from acquisition through public market expansion and exit.
A SHARED DIRECTION
Let’s see what’s possible.
The right conversation can be the beginning of something lasting.